Last updated on December 2018

A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of investigational doses of once weekly dulaglutide when added to metformin in participants with type 2 diabetes with inadequate blood sugar control.

Clinical Study Identifier: NCT03495102

Contact Investigators or Research Sites near you

Start Over

Sina Tebi

Care Access Research
Santa Clarita, CA United States